|
Dr. Peixuan Guo, one of the three top nanobiotechnology experts in the world |
A new study by
University of Kentucky researchers shows promise for developing ultrastable RNA nanoparticles that may help treat cancer and viral infections by regulating cell function and binding to cancers without harming surrounding tissue. The study, published in
Nano Today, was carried out in the laboratory of Peixuan Guo, the
William S. Farish Endowed Chair in Nanobiotechnology at the
UK Markey Cancer Center, in collaboration with Dr. Mark Evers, director of the UK Markey Cancer Center.
"A major problem with cancer treatments is the ability to more directly and specifically deliver anti-cancer drugs to cancer metastases," Evers said. "Using the nanotechnology approach that Peixuan Guo and his group have devised may allow us to more effectively treat cancer metastasis with fewer side effects compared to current chemotherapy." To read more about the study, read the University of Kentucky press release
here. To read study in
Nano Today, go
here.
|
Dr. Peixuan Guo, one of the three top nanobiotechnology experts in the world |
A new study by
University of Kentucky researchers shows promise for developing ultrastable RNA nanoparticles that may help treat cancer and viral infections by regulating cell function and binding to cancers without harming surrounding tissue. The study, published in
Nano Today, was carried out in the laboratory of Peixuan Guo, the
William S. Farish Endowed Chair in Nanobiotechnology at the
UK Markey Cancer Center, in collaboration with Dr. Mark Evers, director of the UK Markey Cancer Center.
"A major problem with cancer treatments is the ability to more directly and specifically deliver anti-cancer drugs to cancer metastases," Evers said. "Using the nanotechnology approach that Peixuan Guo and his group have devised may allow us to more effectively treat cancer metastasis with fewer side effects compared to current chemotherapy." To read more about the study, read the University of Kentucky press release
here. To read study in
Nano Today, go
here.
Read More